P18-14 LB. Vacc-4x HIV p24-like peptide vaccine-associated increase of CD4 T-cells in chronically infected HIV-1 patients on antiretroviral therapy

被引：0
|
作者：
P Bengtsson
I Baksaas
M Sommerfelt
B Sörensen
D Kvale
机构：
[1] Bionor Immuno AS,
[2] Oslo University Hospital,undefined
来源：
Retrovirology | / 6卷
关键词：
Peptide Vaccine; Logical Alternative; Induce Mortality; Induce Stimulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 28 条
  • [21] Immunological markers after long-term treatment interruption in chronically HIV-1 infected patients with CD4 cell count above 400x106 cells/I
    Thiébaut, R
    Pellegrin, I
    Chêne, G
    Viallard, JF
    Fleury, H
    Moreau, JF
    Pellegrin, JL
    Blanco, P
    AIDS, 2005, 19 (01) : 53 - 61
  • [22] Diverse repertoire of HIV-1 p24-specific, IFN-γ-producing CD4+ T cell clones following immune reconstitution on highly active antiretroviral therapy
    Boritz, E
    Palmer, BE
    Livingston, B
    Sette, A
    Wilson, CC
    JOURNAL OF IMMUNOLOGY, 2003, 170 (02): : 1106 - 1116
  • [23] CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy
    Steel, A.
    John, L.
    Shamji, M. H.
    Henderson, D. C.
    Gotch, F. M.
    Gazzard, B. G.
    Kelleher, P.
    HIV MEDICINE, 2008, 9 (02) : 118 - 125
  • [24] Increase in frequencies of circulating Th-17 cells correlates with microbial translocation, immune activation and exhaustion in HIV-1 infected patients with poor CD4 T-cell reconstitution
    Valiathan, Ranjini
    Asthana, Deshratn
    IMMUNOBIOLOGY, 2016, 221 (05) : 670 - 678
  • [25] Human T cell lymphotropic virus type 1 (HTLV-1) infection increases the CD4 count in human immunodeficiency virus type 1 (HIV-1) infected patients submitted to antiretroviral therapy (ARV)
    Filipe FA Rego
    Luiz CJ Alcantara
    Tulio de Oliveira
    Retrovirology, 11 (Suppl 1)
  • [26] Direct-acting antiviral therapy enhances total CD4+and CD8+T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients
    Fard, Saeid Najafi
    Schietromaa, Ivan
    Scheri, Giuseppe Corano
    Giustini, Noemi
    Serafinoa, Sara
    Cavallari, Eugenio Nelson
    Pinacchio, Claudia
    De Girolamo, Gabriella
    Ceccarelli, Giancarlo
    Scagnolari, Carolina
    Vullo, Vincenzo
    d'Ettorre, Gabriella
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (04) : 319 - 329
  • [27] INVITRO GENERATION OF CHRONICALLY HIV-1 INFECTED CD3+CD8+CD4- T-CELLS FROM PERIPHERAL-BLOOD LYMPHOCYTES OF HEALTHY DONORS - VIRUS-REPLICATION IS ASSOCIATED WITH CELL ACTIVATION AND CD8+ CELL-DEATH
    DEMARIA, AF
    PANTALEO, G
    SCHNITTMAN, SM
    FAUCI, AS
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 214 - 214
  • [28] HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4+ T cell loss
    Schüpbach, J
    Günthard, H
    Joos, B
    Fischer, M
    Böni, J
    Tomasik, Z
    Yerly, S
    Perrin, L
    Battegay, M
    Furrer, H
    Vernazza, P
    Bernasconi, E
    Hirschel, B
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (03) : 250 - 256
123